A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers.
The oncologist(2018)
关键词
oxidative phosphorylation inhibitor,advanced cancers,stat3,first-in-human,small-molecule
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要